Financhill
Sell
1

PRQR Quote, Financials, Valuation and Earnings

Last price:
$2.44
Seasonality move :
--
Day range:
$2.40 - $2.68
52-week range:
$1.61 - $4.62
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
10.18x
P/B ratio:
9.19x
Volume:
346.9K
Avg. volume:
500.9K
1-year change:
22.22%
Market cap:
$256.3M
Revenue:
$7.1M
EPS (TTM):
-$0.32

Earnings Data

Next earnings date for PRQR
Mar 13
2025
Most recent earnings per share
-$0.11
Beat by $0.03
(Nov 7/2024)
Consensus Estimate
-$0.14
(Nov 7/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PRQR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 $9M -- -- -- --
03/13/2025 Q4 $7M -- -- -$0.15 --
11/07/2024 Q3 $12.3M $4.2M -$0.11 -$0.14 $0.03
08/08/2024 Q2 $11.2M $6.8M -$0.03 -$0.17 $0.14
05/09/2024 Q1 $2.9M $4.8M -$0.10 -$0.16 $0.06
03/13/2024 Q4 $15.9M $3.5M -$0.08 -$0.12 $0.04
11/07/2023 Q3 -- -- -$0.08 -$0.13 $0.05
08/03/2023 Q2 -- -- -$0.11 -$0.12 $0.01
05/16/2023 Q1 -- -- -$0.12 -$0.10 -$0.02
02/24/2023 Q4 -- -- -$0.19 -$0.19 -$0.00
11/09/2022 Q3 -- -- -$0.34 -$0.23 -$0.11
08/04/2022 Q2 -- -- -$0.22 -$0.22 -$0.00
05/05/2022 Q1 -- -- -$0.22 -$0.28 $0.05
02/24/2022 Q4 -- -- -$0.30 -$0.12 -$0.18
11/04/2021 Q3 -- -- -$0.26 -$0.24 -$0.02
08/05/2021 Q2 -- -- -$0.29 -$0.27 -$0.02
05/06/2021 Q1 -- -- -$0.30 -$0.30 -$0.00
02/25/2021 Q4 -- -- -$0.31 -$0.31 $0.00
11/16/2020 Q3 -- -- -$0.30 -$0.39 $0.09
08/06/2020 Q2 -- -- -$0.09 -$0.35 $0.26
05/07/2020 Q1 -- -- -$0.35 -$0.36 $0.01
02/26/2020 Q4 -- -- -$0.43 -$0.37 -$0.06
11/06/2019 Q3 -- -- -$0.34 -$0.38 $0.03
08/07/2019 Q2 -- -- -$0.34 -$0.43 $0.09
05/08/2019 Q1 -- -- -$0.40 -$0.38 -$0.02
02/27/2019 Q4 -- -- -$0.38 -$0.30 -$0.08
11/07/2018 Q3 -- -- -$0.21 -$0.31 $0.11
08/08/2018 Q2 -- -- -$0.27 -$0.47 $0.20
03/31/2018 Q1 -- -- -$0.40 -$0.40 -$0.00
02/28/2018 Q4 -- -- -$0.48 -$0.45 -$0.03
11/20/2017 Q3 -- -- -$0.49 -$0.50 $0.01
08/16/2017 Q2 -- -- -$0.55 -$0.51 -$0.04
03/31/2017 Q1 -- -- -$0.50 -$0.51 $0.01
02/28/2017 Q4 -- -- -- -- --
11/14/2016 Q3 -- -- -- -- --
08/17/2016 Q2 -- -- -- -- --
05/19/2016 Q1 -- -- -- -- --
02/25/2016 Q4 -- -- -- -- --
11/23/2015 Q3 -- -- -- -- --
08/20/2015 Q2 -- -- -- -- --
05/28/2015 Q1 -- -- $0.01 -- --

ProQR Therapeutics NV Earnings Questions

  • How Much did ProQR Therapeutics NV Generate in Revenue Last Quarter?

    ProQR Therapeutics NV reported $4.2M worth of top line sales in its most recent quarter.

  • Did ProQR Therapeutics NV Beat Earnings Last Quarter?

    ProQR Therapeutics NV announced earnings per share of -$0.11 which represents a beat of analyst forecast a -$0.14 per share.

  • Is ProQR Therapeutics NV Profitable?

    ProQR Therapeutics NV reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for ProQR Therapeutics NV EPS Next Year?

    ProQR Therapeutics NV's earnings are forecast to decrease from -$0.38 per share to -$0.48 per share next year representing a decrease of -48.58%.

  • When is ProQR Therapeutics NV's Earnings Date?

    ProQR Therapeutics NV's next earnings date is March 13, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Broadcom Stock Overvalued?
Is Broadcom Stock Overvalued?

The semiconductor company Broadcom Inc. (NASDAQ:AVGO) is having a stellar…

4 Top Dividend Stocks to Buy Now
4 Top Dividend Stocks to Buy Now

If you’re looking for steady income, dividend stocks are a…

Will Uber Stock Recover?
Will Uber Stock Recover?

Shares of Uber Technologies (NYSE:UBER) have had a rough few…

Stock Ideas

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 39x

Sell
47
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 114x

Sell
39
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 36x

Alerts

Buy
87
CEG alert for Jan 11

Constellation Energy [CEG] is up 25.15% over the past day.

Sell
1
MCY alert for Jan 11

Mercury General [MCY] is down 19.87% over the past day.

Buy
84
ATZAF alert for Jan 11

Aritzia [ATZAF] is up 17.63% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock